01PetMed Express reported Q1 2026 earnings per share of -$0.28, missing the consensus estimate of $0.12 by $0.40 per share, representing a 333% negative surprise.
02Revenue of $41.0M beat analyst expectations of $10.3M, though the company remains unprofitable with a market capitalization of $61.4M.
03The company has reported losses in four consecutive quarters, with Q4 2025 showing a -$0.56 EPS versus a -$0.05 estimate, indicating a pattern of deteriorating profitability.
Earnings Results
PetMed Express (NASDAQ:PETS) reported quarterly earnings results on August 13, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $-0.28, missing the consensus estimate of $0.12 by $0.40 per share. Revenue came in at $41.0M, beating the estimate of $10.3M.
Company Overview
PetMed Express's stock moved following the earnings release. The stock currently trades at $2.03 with a market capitalization of $61.4M.
Missing analyst estimates puts pressure on a stock as investors reassess their growth assumptions. The market's reaction to an earnings miss depends heavily on the magnitude of the shortfall, the company's forward guidance, and whether the miss was driven by temporary or structural factors.
The 333% miss relative to consensus estimates is a notable deviation. Earnings surprises of this magnitude often trigger analyst revisions and can influence institutional positioning in the weeks following the report.
Earnings reports are most useful when viewed as part of a trend rather than in isolation. Investors tracking PetMed Express should compare this quarter's results against both year-over-year figures and sequential performance to identify whether the business is accelerating, stabilizing, or decelerating. The earnings calendar on Smart Investors Daily tracks upcoming report dates across all publicly traded companies.